Copyright
©The Author(s) 2021.
Artif Intell Gastroenterol. Feb 28, 2021; 2(1): 1-9
Published online Feb 28, 2021. doi: 10.35712/aig.v2.i1.1
Published online Feb 28, 2021. doi: 10.35712/aig.v2.i1.1
- Citation: Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artif Intell Gastroenterol 2021; 2(1): 1-9
- URL: https://www.wjgnet.com/2644-3236/full/v2/i1/1.htm
- DOI: https://dx.doi.org/10.35712/aig.v2.i1.1